Efficient discovery of anti-inflammatory small molecule combinations using evolutionary computing
暂无分享,去创建一个
Joshua D. Knowles | D. Kell | P. Mendes | B. Small | B. McColl | R. Allmendinger | J. Pahle | G. López-Castejón | N. Rothwell | D. Brough | Jürgen Pahle
[1] J. Relton,et al. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat , 1992, Brain Research Bulletin.
[2] W. Greco,et al. The search for synergy: a critical review from a response surface perspective. , 1995, Pharmacological reviews.
[3] D A Fell,et al. Physiological control of metabolic flux: the requirement for multisite modulation. , 1995, The Biochemical journal.
[4] C. Dinarello,et al. Biologic basis for interleukin-1 in disease. , 1996, Blood.
[5] Zbigniew Michalewicz,et al. Handbook of Evolutionary Computation , 1997 .
[6] P. Ponka,et al. The antioxidant effects of a novel iron chelator salicylaldehyde isonicotinoyl hydrazone in the prevention of H(2)O(2) injury in adult cardiomyocytes. , 2000, Cardiovascular research.
[7] Y. W. Lee,et al. Dexamethasone inhibits IL-1 beta gene expression in LPS-stimulated RAW 264.7 cells by blocking NF-kappa B/Rel and AP-1 activation. , 2000, Immunopharmacology.
[8] Yong Woo Lee,et al. Dexamethasone inhibits IL-1β gene expression in LPS-stimulated RAW 264.7 cells by blocking NF-κB/Rel and AP-1 activation , 2000 .
[9] Evan J. Hughes,et al. Evolutionary Multi-objective Ranking with Uncertainty and Noise , 2001, EMO.
[10] David E. Goldberg,et al. The Design of Innovation: Lessons from and for Competent Genetic Algorithms , 2002 .
[11] Gary B. Lamont,et al. Evolutionary Algorithms for Solving Multi-Objective Problems , 2002, Genetic Algorithms and Evolutionary Computation.
[12] D. Kell,et al. Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era. , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.
[13] Eckart Zitzler,et al. Indicator-Based Selection in Multiobjective Search , 2004, PPSN.
[14] Joshua D. Knowles,et al. Closed-loop, multiobjective optimization of analytical instrumentation: gas chromatography/time-of-flight mass spectrometry of the metabolomes of human serum and of yeast fermentations. , 2005, Analytical chemistry.
[15] Gary B. Lamont,et al. Evolutionary Algorithms for Solving Multi-Objective Problems (Genetic and Evolutionary Computation) , 2006 .
[16] H. Kitano,et al. A comprehensive map of the toll-like receptor signaling network , 2006, Molecular systems biology.
[17] G. V. Paolini,et al. Global mapping of pharmacological space , 2006, Nature Biotechnology.
[18] Hon Keung Tony Ng,et al. Statistics: An Introduction Using R , 2006, Technometrics.
[19] P. Sorger,et al. Systems biology and combination therapy in the quest for clinical efficacy , 2006, Nature chemical biology.
[20] M. Krams,et al. Innovative Approaches for Designing and Analyzing Adaptive Dose-Ranging Trials , 2007, Journal of biopharmaceutical statistics.
[21] J. Lehár,et al. Multi-target therapeutics: when the whole is greater than the sum of the parts. , 2007, Drug discovery today.
[22] Joshua D. Knowles,et al. Multiobjective Optimization in Bioinformatics and Computational Biology , 2007, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[23] Kalyanmoy Deb,et al. Multiobjective Problem Solving from Nature: From Concepts to Applications (Natural Computing Series) , 2008 .
[24] C. Löfdahl. COPD and co‐morbidities, with special emphasis on cardiovascular conditions , 2008, The clinical respiratory journal.
[25] D. Kell,et al. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? , 2008, Nature Reviews Drug Discovery.
[26] R. Sun,et al. Closed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithm , 2008, Proceedings of the National Academy of Sciences.
[27] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[28] Kalyanmoy Deb,et al. Multiobjective Problem Solving from Nature: From Concepts to Applications , 2008, Natural Computing Series.
[29] Corey Nislow,et al. Combination chemical genetics. , 2008, Nature chemical biology.
[30] D. Kell. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases , 2008, BMC Medical Genomics.
[31] W. Yeh,et al. LPS/TLR4 signal transduction pathway. , 2008, Cytokine.
[32] Joshua D. Knowles. Closed-loop evolutionary multiobjective optimization , 2009, IEEE Computational Intelligence Magazine.
[33] D. Kell,et al. Array-based evolution of DNA aptamers allows modelling of an explicit sequence-fitness landscape , 2008, Nucleic acids research.
[34] Xiaohua Ma,et al. Mechanisms of drug combinations: interaction and network perspectives , 2009, Nature Reviews Drug Discovery.
[35] Ren Sun,et al. Integrative systems control approach for reactivating Kaposi's sarcoma-associated herpesvirus (KSHV) with combinatory drugs. , 2009, Integrative biology : quantitative biosciences from nano to macro.
[36] D. Brough,et al. Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy , 2009, British journal of pharmacology.
[37] John A. Tallarico,et al. Multi-parameter phenotypic profiling: using cellular effects to characterize small-molecule compounds , 2009, Nature Reviews Drug Discovery.
[38] Susan E. Abbatiello,et al. Erratum: Synergistic drug combinations tend to improve therapeutically relevant selectivity , 2009, Nature Biotechnology.
[39] Xiaohua Ma,et al. Mechanisms of drug combinations: interaction and network perspectives , 2009, Nature Reviews Drug Discovery.
[40] E. Tobinick. The value of drug repositioning in the current pharmaceutical market. , 2009, Drug news & perspectives.
[41] R. K. Ursem. Multi-objective Optimization using Evolutionary Algorithms , 2009 .
[42] Jeremy E Purvis,et al. Pairwise agonist scanning predicts cellular signaling responses to combinatorial stimuli , 2010, Nature Biotechnology.
[43] K. Shokat,et al. Targeting the cancer kinome through polypharmacology , 2010, Nature Reviews Cancer.
[44] Jorge Cortes,et al. Systems approaches and algorithms for discovery of combinatorial therapies. , 2009, Wiley interdisciplinary reviews. Systems biology and medicine.
[45] U. Alon,et al. Protein Dynamics in Drug Combinations: a Linear Superposition of Individual-Drug Responses , 2010, Cell.
[46] G. Firestein,et al. “Go upstream, young man”: lessons learned from the p38 saga , 2009, Annals of the rheumatic diseases.
[47] Carl Nathan,et al. Nonresolving Inflammation , 2010, Cell.
[48] Joshua D. Knowles,et al. Evolutionary Optimization on Problems Subject to Changes of Variables , 2010, PPSN.
[49] J. Pfeilschifter,et al. SphK1 Regulates Proinflammatory Responses Associated with Endotoxin and Polymicrobial Sepsis , 2010, Science.
[50] P. Scully,et al. Plasma Cytokine Profiles in Females With Irritable Bowel Syndrome and Extra-Intestinal Co-Morbidity , 2010, The American Journal of Gastroenterology.
[51] Douglas B. Kell,et al. Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples , 2010, Archives of Toxicology.
[52] David DeCaprio,et al. Cheminformatics approaches to analyze diversity in compound screening libraries. , 2010, Current opinion in chemical biology.
[53] Mike Tyers,et al. Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy. , 2011, Nature chemical biology.
[54] C. Dinarello,et al. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. , 2011, Blood.
[55] Cord Sunderkötter,et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. , 2011, The Journal of clinical investigation.